Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study

Annals of Neurology

Volumn 70, Issue 1, 2011, Pages 79-83

  Schrooten, Maarten ^a   Smetcoren, Charlotte ^a   Robberecht, Wim ^a,b   Van Damme, Philip ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AWAJI DIAGNOSTIC ALGORITHM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EL ESCORIAL CRITERIA; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTONEURON; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVE CELL DEGENERATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AGED; ALGORITHMS; AMYOTROPHIC LATERAL SCLEROSIS; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79960804734     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22380     Document Type: Article

References (20)

1. Chio A, Mora G, Calvo A, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009; 72: 725-731.
2. Johnston CA, Stanton BR, Turner MR, et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 2006; 253: 1642-1643. (Pubitemid 46116727)
3. Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010; 81: 385-390.
4. Verma A, Bradley WG., Atypical motor neuron disease and related motor syndromes. Semin Neurol 2001; 21: 177-187. (Pubitemid 32578729)
5. Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology 2006; 66: 647-653. (Pubitemid 43739816)
6. Kim WK, Liu X, Sandner J, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009; 73: 1686-1692.
7. Brooks BR., El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124 (suppl): 96-107.
8. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
9. Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003; 74: 1258-1261.
10. de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119: 497-503.
11. Andersen PM, Borasio GD, Dengler R, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005; 12: 921-938. (Pubitemid 41823891)
12. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218-1226.
13. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1227-1233.
14. de Carvalho MD, Swash M., Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 2009; 10: 53-57.
15. Douglass CP, Kandler RH, Shaw PJ, et al. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 2010; 81: 646-649.
16. Boekestein WA, Kleine BU, Hageman G, et al. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: Retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler 2010; 11: 497-501.
17. Chen A, Weimer L, Brannagan T, 3rd, et al. Experience with the Awaji Island modifications to the ALS diagnostic criteria. Muscle Nerve 2010; 42: 831-832.
18. Ludbrook J, Dudley H., Issues in biomedical statistics: analysing 2 à- 2 tables of frequencies. Aust N Z J Surg 1994; 64: 780-787. (Pubitemid 24338940)
19. Brooks BR, Sufit RL, DePaul R, et al. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 521-546.
20. Miller RG, Munsat TL, Swash M, et al. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research. J Neurol Sci 1999; 169: 2-12. (Pubitemid 29502500)